Scarica l'app Stockscreener
4.15
1.43%
-0.06
Dopo l'orario di chiusura:
4.15
Precedente Chiudi:
$4.21
Aprire:
$4.24
Volume 24 ore:
147.17K
Relative Volume:
0.80
Capitalizzazione di mercato:
$205.13M
Reddito:
$7.15M
Utile/perdita netta:
$-20.60M
Rapporto P/E:
8.7442
EPS:
0.4746
Flusso di cassa netto:
$-97.99M
1 W Prestazione:
+2.72%
1M Prestazione:
+18.57%
6M Prestazione:
+97.62%
1 anno Prestazione:
+162.66%
Intervallo 1D:
$4.13
$4.27
Intervallo di 1 settimana:
$3.77
$4.33
Portata 52W:
$1.55
$4.4799
Whitehawk Therapeutics Inc Stock (WHWK) Company Profile
Nome
Whitehawk Therapeutics Inc
Settore
Industria
Telefono
551-321-2234
Indirizzo
2 HEADQUARTERS PLAZA, MORRISTOWN
Compare WHWK vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
WHWK
Whitehawk Therapeutics Inc
|
4.15 | 208.09M | 7.15M | -20.60M | -97.99M | 0.4746 |
VRTX
Vertex Pharmaceuticals Inc
|
427.52 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
721.05 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
807.55 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
303.01 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
313.32 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Whitehawk Therapeutics Inc Stock (WHWK) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-05 | Iniziato | Oppenheimer | Outperform |
| 2024-08-27 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-08-21 | Downgrade | Jefferies | Buy → Hold |
| 2024-08-21 | Downgrade | TD Cowen | Buy → Hold |
| 2023-12-15 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2022-01-11 | Iniziato | Jefferies | Buy |
| 2021-10-01 | Iniziato | Cowen | Outperform |
| 2021-09-14 | Iniziato | Ladenburg Thalmann | Buy |
| 2021-09-08 | Iniziato | Piper Sandler | Overweight |
Mostra tutto
Whitehawk Therapeutics Inc Borsa (WHWK) Ultime notizie
The sustainable advantages Whitehawk Therapeutics (WHWK) is developing (Eye on Rally) 2026-05-05Hot Stocks - Newser
Whitehawk Therapeutics Inc expected to post a loss of 9 cents a shareEarnings Preview - TradingView
Whitehawk Therapeutics (WHWK) price target increased by 10.29% to 6.38 - MSN
Whitehawk Therapeutics (WHWK) price target increased by 13.33% to 5.78 - MSN
[ARS] Whitehawk Therapeutics, Inc. SEC Filing - Stock Titan
Whitehawk Therapeutics (NASDAQ: WHWK) details 2026 virtual shareholder meeting - Stock Titan
ABG Innovation Capital Partners III GP Ltd's Whitehawk Therapeutics Inc(WHWK) Holding History - GuruFocus
WHWK Whitehawk Therapeutics falls 3.36% as Q4 2025 EPS misses estimates by a wide 116.4 percent margin.Collaborative Trading Signals - Newser
Whitehawk jumps as Citizens issues outperform rating ahead of trial data - MSN
Oppenheimer Maintains Whitehawk Therapeutics(WHWK.US) With Buy Rating, Maintains Target Price $6 - Moomoo
WHWK Whitehawk Therapeutics posts wider than projected Q4 2025 loss, pushing its share price down 3.36% today.Stock Market Community - Newser
Whitehawk Therapeutics' Antibody Drug Conjugates Indicate Potential Efficacy Against Cancer, Oppenheimer Says - Moomoo
H.C. Wainwright Maintains Whitehawk Therapeutics(WHWK.US) With Hold Rating - Moomoo
Whitehawk Therapeutics (WHWK) Unveils New Preclinical Data at AA - GuruFocus
Whitehawk Therapeutics Presents Comprehensive Preclinical Data Highlighting its Next-Generation ADC Portfolio at the AACR 2026 - InsideNoVa.com
What is driving sentiment for Whitehawk Therapeutics (WHWK) stock (On the Radar) 2026-04-18Trending Entry Points - Xã Thanh Hà
Whitehawk Therapeutics CFO sells $882k in stock - Investing.com
Whitehawk Therapeutics CFO sells $882k in stock By Investing.com - Investing.com Australia
Whitehawk Therapeutics Chief Financial Officer Sold Shares Worth Over $882K - TradingView
Whitehawk Therapeutics (WHWK) CFO disposes shares in tax-related broker sales - Stock Titan
Whitehawk Therapeutics to Participate in Jones Trading Post-AACR Fireside Chat Series - The AI Journal
Whitehawk stock wins Outperform rating from Citizens (WHWK) - Seeking Alpha
WHWK Initiated Coverage by Citizens -- Rating Set to Market Outp - GuruFocus
Whitehawk Therapeutics stock initiated with outperform rating at Citizens By Investing.com - Investing.com South Africa
Whitehawk Therapeutics stock initiated with outperform rating at Citizens - Investing.com
Proposed resale lists 473,902 units; insider sold 2,594 shares (WHWK) - Stock Titan
Whitehawk Therapeutics officer Ball sells $427,860 in stock - Investing.com
Whitehawk Therapeutics officer Ball sells $427,860 in stock By Investing.com - Investing.com South Africa
Whitehawk Therapeutics (WHWK) officer sells 118,849 shares for RSU tax withholding - Stock Titan
WHWK Stock Price and Chart — NASDAQ:WHWK - TradingView
Discovering Whitehawk Therapeutics Among 3 Promising Penny Stocks - Yahoo Finance
Whitehawk Therapeutics officer Ball sells $201k in stock By Investing.com - Investing.com South Africa
Whitehawk Therapeutics officer Ball sells $201k in stock - Investing.com
Whitehawk Therapeutics (WHWK) insider disposes 56,596 shares for tax withholding - Stock Titan
EV Market: Will Whitehawk Therapeutics Inc benefit from government policyWeekly Stock Report & Free Community Supported Trade Ideas - baoquankhu1.vn
WHWK SEC FilingsWhitehawk Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Trade Alert: President Of Whitehawk Therapeutics David Lennon Has Sold Stock - simplywall.st
Whitehawk Therapeutics Inc Azioni (WHWK) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.77%
0.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):